How have ONPH shares performed in 2024?

Oncology Pharma's stock was trading at $0.0002 at the start of the year. Since then, ONPH shares have increased by 150.0% and is now trading at $0.0005. View the best growth stocks for 2024 here .

How do I buy shares of Oncology Pharma?

Shares of ONPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:ONPH

Oncology Pharma (ONPH) Stock Price, News & Analysis

→ Henry Kissinger’s chilling AI warning (From Chaikin Analytics) (Ad)

Free ONPH Stock Alerts

$0.0005

0.00 (0.00%)

(As of 04/17/2024 ET)

Compare

Today's Range: $0.0005
▼
$0.0005
50-Day Range: N/A
52-Week Range: $0.00
▼
$1.05

Volume: 1,459 shs
Average Volume: 3,837 shs
Market Capitalization: $19,330.00

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Headlines Short Interest

Get Oncology Pharma alerts:

Ad Chaikin Analytics

Henry Kissinger’s chilling AI warning

Not long before his death in 2023, Henry Kissinger wrote about a "world of potentially total destructiveness and substantial uncertainty." He was talking about the advent of generative artificial intelligence (AI)... And how we are woefully unprepared for the consequences this technology could bring.

Just click right here to access this new research 100% free while it’s still available.

About Oncology Pharma Stock (OTCMKTS:ONPH)

Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc. in June 2019. Oncology Pharma Inc. was incorporated in 1993 and is based in San Francisco, California.

ONPH Stock Price History

30 days | 90 days | 365 days | Advanced Chart

ONPH Stock News Headlines

April 17, 2024 | markets.businessinsider.com

Nika Pharmaceuticals, Inc. (NKPH) Purchased the Technologies for Three Drugs in Tablet Form and One Dietary Supplement

April 12, 2024 | bloomberg.com

Nuclear Medicine Is Big Pharma’s New Target in Cancer Race

April 18, 2024 | Chaikin Analytics (Ad)

Henry Kissinger’s chilling AI warning

April 10, 2024 | businesswire.com

Onchilles Pharma Presents at AACR 2024 New Preclinical Data for N17350 and N17465 Demonstrating the Potential for Potent and Tumor-Selective Treatment

April 9, 2024 | msn.com

Boehringer Ingelheim Upbeat On China, Forms Cancer Drug Partnership

April 4, 2024 | msn.com

Kintara and TuHURA enter merger deal to advance oncology pipeline

April 4, 2024 | msn.com

Cancer biotech firm Alterome Therapeutics raises $132 mln in Goldman Sachs-led round

April 4, 2024 | msn.com

A new hope in immunotherapy against cancer

April 18, 2024 | Chaikin Analytics (Ad)

Henry Kissinger’s chilling AI warning

March 26, 2024 | msn.com

Regeneron's blood cancer therapy faces setback as FDA raises trial concerns

March 25, 2024 | msn.com

US FDA declines to approve Regeneron's blood cancer therapy

March 21, 2024 | bizjournals.com

Clinical trial results show new Penn technology could be the key to fighting brain cancer

March 12, 2024 | msn.com

AbilityPharma receives funds to advance pancreatic cancer trial

March 4, 2024 | msn.com

Iovance stock rises after FDA lifts clinical hold on lung cancer trial

February 27, 2024 | benzinga.com

Oncology Pharma Stock (OTC:ONPH) Dividends: History, Yield and Dates

February 27, 2024 | benzinga.com

Oncology Pharma Stock (OTC:ONPH), Analyst Ratings, Price Targets, Predictions

February 20, 2024 | msn.com

The doctor behind the next big thing in cancer treatment

February 20, 2024 | msn.com

The woman behind the next big thing in cancer treatment

February 19, 2024 | msn.com

Positive signs for new cancer treatment after trial on Oxford patients

February 17, 2024 | msn.com

UPDATE 3-US FDA grants accelerated approval for Iovance's skin cancer cell therapy

February 16, 2024 | reuters.com

US FDA grants accelerated approval for Iovance's skin cancer cell therapy

February 15, 2024 | msn.com

Cancer breakthrough as doctors celebrate new ‘wonder drug’

February 15, 2024 | msn.com

Ono and Numab to develop antibody for cancer treatment

February 9, 2024 | msn.com

Boehringer and CBmed partner to develop cancer therapies

February 4, 2024 | tmcnet.com

Accord Healthcare partners with ITN Business for World Cancer Day to explore how innovative approaches are helping shape the future of cancer care

February 2, 2024 | msn.com

NeoPhore adds $12.2m in Series B extension for immuno-oncology pipeline

January 30, 2024 | msn.com

Kiromic BioPharma reports data from lung cancer therapy trial

See More Headlines

Receive ONPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oncology Pharma and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/18/2024
Fiscal Year End: 3/31/2025

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Prepackaged software
Sub-Industry: N/A
Current Symbol: OTCMKTS:ONPH
CUSIP: N/A
CIK: N/A
Web: www.oncology-pharma.com
Phone: (415) 869-1038
Fax: 858-385-8997
Employees: 1
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 38,660,000
Free Float: 31,704,000
Market Cap: $19,330.00
Optionable: Not Optionable
Beta: -0.91

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

Mr. Chuck Wagner
President, Treasurer & Chairman
Mr. George Malesek
Interim Chief Executive Officer
Mr. Dimitri Theofilopolous Esq.
Legal Counsel

Key Competitors

View All Competitors

ONPH Stock Analysis - Frequently Asked Questions

How have ONPH shares performed in 2024?: Oncology Pharma's stock was trading at $0.0002 at the start of the year. Since then, ONPH shares have increased by 150.0% and is now trading at $0.0005.
View the best growth stocks for 2024 here.
How do I buy shares of Oncology Pharma?: Shares of ONPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:ONPH) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Oncology Pharma (ONPH) Stock Price, News & Analysis

About Oncology Pharma Stock (OTCMKTS:ONPH)

ONPH Stock Price History

ONPH Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

ONPH Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info